eFFECTOR Therapeutics, Inc. (EFTR) PT Lowered to $4 at Stifel, Analyst Reiterates Hold, Awaits Proof-of-Concept tomivosertib Data
Tweet Send to a Friend
Stifel analyst Benjamin J. Burnett lowered the price target on eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) to $4.00 (from $6.20) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
